Comtech Telecommunications Corp.

Third-quarter net sales were $106 million, down from $126.8 million a year ago. Gross profit was $36.1 million, or 34% of net sales, versus $38.9 million, or 30.7% last year. Operating loss was $3.1 million versus an operating loss of $1.5 million last year; adjusted EBITDA was $8.2 million versus $12.6 million. Net bookings were $70.5 million, with a book-to-bill ratio of 0.67, versus $71 million and 0.56 last year. Operating cash flow was $6.1 million, up from $2.3 million, and this was the fifth consecutive quarter of positive operating cash inflows. Segmentally, S&S net sales were $50.3 million and Allerium net sales were $55.7 million; S&S adjusted EBITDA was $4.1 million and Allerium adjusted EBITDA was $10.4 million. The company expects net proceeds from the S&S sale of approximately $143 million to $145 million, to be used for debt reduction and recapitalization. In addition, management said the sale plus the credit and preferred stock amendments strengthen liquidity and financial flexibility, and that covenant testing on leverage and related metrics is suspended until July 31, 2027.

Ken Traub framed the quarter as proof that Comtech has executed on all four pillars of its turnaround: operational discipline, positive cash flow, strategic review, and capital structure repair. His tone was confident and reflective, emphasizing that the company reached a 'position of strength' before selling most of S&S and that the transaction lets Comtech focus on Allerium as a public-safety technology business. He highlighted a future centered on NextGen 911, call handling, location-based services, data management, and AI-enabled emergency response.

Mike Bondi emphasized improving operating quality, saying the company delivered another quarter of positive operating cash flow and continued gross margin strength. He pointed to gross profit of $36.1 million, or 34% of sales, adjusted EBITDA of $8.2 million, and the fifth consecutive quarter of positive operating cash flow. He also detailed the balance-sheet changes: about $49.4 million of liquidity at April 30, 2026, about $50 million as of June 12, 2026, $119.7 million then $116 million of senior debt, $104.1 million then $104.8 million of subordinated debt, and a preferred liquidation preference of $218.2 million then $220.5 million. He said the sale proceeds will be split 65% to senior debt and 35% to subordinated debt, and that covenant testing has been suspended until July 31, 2027.

Analysts pressed on why sell now rather than wait for more S&S value; management said they had to balance timing against the company’s heavy capital structure and believed they had reached the right position of strength to optimize the long-term future. Questions also focused on the post-deal capital structure, and Ken said the proceeds should largely retire senior debt and materially reduce subordinated debt, leaving a 'clean and healthy' structure after refinancing. Mike Crawford asked about change-of-control risk, and Ken said all stakeholders agree the transaction is not a change of control and does not trigger preferred liquidation preferences. On Allerium, management said recurring revenue is a significant and growing portion of the business, backlog is $554 million, and re-competes should play to its direct relationships with states and its NextGen 9-1-1/network capabilities.